Results 161 to 170 of about 3,910,323 (355)

Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats. [PDF]

, 1993
S. Gotoh, Junichi Onaya, Masahiko Abe, Kyosuke Miyazaki, Akio Hamai, Katsuyuki Horie, Kiyochika Tokuyasu   +6 more
openalex   +1 more source

β‐TrCP overexpression enhances cisplatin sensitivity by depleting BRCA1

Molecular Oncology, EarlyView.
Low levels of β‐TrCP (Panel A) allow the accumulation of BRCA1 and CtIP, which facilitate the repair of cisplatin‐induced DNA damage via homologous recombination (HR) and promote tumor cell survival. In contrast, high β‐TrCP expression (Panel B) leads to BRCA1 and CtIP degradation, impairing HR repair, resulting in persistent DNA damage and apoptosis ...
Rocío Jiménez‐Guerrero, Alejandro Belmonte‐Fernández, Mónica González‐Moreno, Laura Rodríguez‐Cordero, Begoña Pérez‐Valderrama, Joaquín Herrero‐Ruíz, Francisco Romero, Carmen Sáez, Miguel Á. Japón   +8 more
wiley   +1 more source

Mechanism of action of sodium hypochlorite

Brazilian Dental Journal, 2002
The choice of an irrigating solution for use in infected root canals requires previous knowledge of the microorganisms responsible for the infectious process as well as the properties of different irrigating solutions.
Estrela Carlos, Estrela Cyntia R.A., Barbin Eduardo Luis, Spanó Júlio César E., Marchesan Melissa A., Pécora Jesus D.   +5 more
doaj  

RBE and the primary mechanism of radiation action [PDF]

, 1971
Kellerer, Albrecht M., Rossi, H. H.
core   +1 more source

STUDIES ON THE MECHANISMS FOR ACTION OF FIBROBLAST GROWTH FACTORS IN STROMAL CELLS OF HYPERPLASTIC HUMAN PROSTATE

, 1995
Akio Matsubara
openalex   +2 more sources

Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies [PDF]

, 2013
Melvin Berger, Daniel E. McCallus, Cindy Lin   +2 more
openalex   +1 more source

Mechanisms of action

, 2010
Françoise van Bambeke, Marie-Paule Mingeot-Leclercq, Youri Glupczynski, Paul M. Tulkens   +3 more
openaire   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Action Mechanism of Phenazine-5N-monooxide against Rice Leaf Blight Bacterium

, 1969
Tetsuro Watanabe, Yasuharu SEKIZAWA
openalex   +2 more sources

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source